Remission of new-onset type 2 diabetes mellitus in an adolescent using an integrative medicine approach: A case report.
10.1016/j.joim.2020.10.005
- Author:
Baoyi SHAO
1
;
Saiying HOU
1
;
Yuenyan CHAN
1
;
Changchun SHAO
2
,
3
;
Lixing LAO
4
Author Information
1. Clinical Division, Beijing Changchun Hospital of Traditional Chinese Medicine, Beijing 100123, China.
2. Clinical Division, Beijing Changchun Hospital of Traditional Chinese Medicine, Beijing 100123, China. Electronic address: shaochangchun1965@
3. com.
4. Virginia University of Integrative Medicine, Fairfax, VA 2203, USA. Electronic address: llao@vuim.edu.
- Publication Type:Case Reports
- Keywords:
Case report;
Integrative medicine;
Traditional Chinese medicine;
Type 2 diabetes mellitus
- From:
Journal of Integrative Medicine
2021;19(1):85-88
- CountryChina
- Language:English
-
Abstract:
Among adolescents, the incidence of type 2 diabetes mellitus (T2DM) has recently increased. A 12-year-old Chinese boy with a one-year history of hyperphagia presented to our clinic. The patient was diagnosed with T2DM one month prior to visiting the clinic and reported undergoing no pharmacologic treatment. Using an integrative medicine approach, including Chinese herbal decoction, berberine hydrochloride tablets, physical exercise and diet control, the patient's fasting blood glucose (FBG) decreased from 8.3 mmol/L to 5.5 mmol/L. Additionally, his glycated haemoglobin decreased from 12.9% to 6.1%, indicating that without any Western medicine intervention his diabetes has been reversed after six months of treatment. His FBG remained normal, and nine months after completion of treatment it was 4.9 mmol/L. A potential mechanism in this response may be related to improved insulin resistance and β-cell function, as indicated by observed changes in homeostasis model assessment of insulin resistance and β-cell function. Further, weight loss may also have contributed to the effectiveness of the treatment. This case study is the first to present the innovative approach of integrative medicine to achieve remission of new-onset adolescent T2DM.
